GABA — Gabather AB Share News
0.000.00%
Last trade - 00:00- SEK14.41m
- SEK10.72m
Brief: Gabather Q2 Pretax Loss Narrows To SEK 2.6 Million
Brief: Gabather: Positive Relim Results From First Dose Level In Phase 1 Study With Gt-002
Brief: Gabather Concentrates All Company Operations To Södertälje
Brief: Gabather Q1 Pre-Tax Loss Widens To SEK 4.3 Mln
Brief: Gabather Q4 Pre-Tax Loss Narrows To SEK 3.7 Million
Brief: Gabather AB Submits Clinical Trial Application To Further Advance Development Of GT-002
Brief: Gabather AB Q3 Result After Financial Posts at loss SEK 2.7 mln
Brief: Gabather Carries Out Rights Issue Of About SEK 62 Million
Brief: Gabather Q2 Pre-Tax Loss Narrows To SEK 4.2 Million
Brief: Gabather Study Shows GT-002 To Be Safe And Well-Tolerated
Brief: Gabather Q1 Pretax Loss Narrows To SEK 3.7 Million
Brief: Gabather Preliminary Analysis Shows GT-002 Is Safe, Well Tolerated
Brief: Gabather Q4 Pre-Tax Loss Narrows To SEK 4.1 Million
Brief: Gabather Q3 Pre-Tax Loss Widens To SEK 5.1 Million
Brief: Gabather Q2 Pretax Loss Sek 6.1 Million
Brief: Gabather Completes Toxicological Studies
Brief: Gabather CEO Dr. Bert Junno Resigns
Brief: Gabather Q1 Pretax Loss SEK 4.7 mln
Brief: Gabather AB Q4 Revenue Down At Sek 472,000